Sustained delivery by leucine-modified chitosan spray-dried respirable powders.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International journal of pharmaceutics

• Publication date

  2009-05-08

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2009.01.017PMID 19429272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders

  2008cited by this paper
• Novel long‐acting bronchodilators for COPD and asthma

  2008cited by this paper
• Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.

  2008cited by this paper
• An investigation into solvent‐membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes

  2008cited by this paper
• Treatment strategies for allergy and asthma

  2008cited by this paper
• Spray-dried powders for pulmonary drug delivery.

  2007cited by this paper
• Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery

  2007cited by this paper
• Particle design using a 4-fluid-nozzle spray-drying technique for sustained release of acetaminophen.

  2006cited by this paper
• Most difficult asthma originates primarily in adult life.

  2006cited by this paper
• The mechanisms, diagnosis, and management of severe asthma in adults.

  2006cited by this paper
• Assessment of mucoadhesion by a resonant mirror biosensor.

  2006cited by this paper
• Particle design of three-component system for sustained release using a 4-fluid nozzle spray-drying technique.

  2006cited by this paper
• Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.

  2006cited by this paper
• Preparation and characterization of chitosan/gelatin microcapsules containing triclosan.

  2006cited by this paper
• Natural polymers for gene delivery and tissue engineering.

  2006cited by this paper
• Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.

  2006cited by this paper
• Osmotic flow through asymmetric membrane: A means for controlled delivery of drugs with varying solubility

  2006cited by this paper
• Primary microparticles and agglomerates of morphine for nasal insufflation.

  2006cited by this paper
• Characterization of spray-dried tuna oil emulsified in two-layered interfacial membranes prepared using electrostatic layer-by-layer deposition

  2006cited by this paper
• Spray-dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer

  2006cited by this paper
• Chitosan-Modified Dry Powder Formulations for Pulmonary Gene Delivery

  2006cited by this paper
• Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.

  2006cited by this paper
• The use of amino acids to enhance the aerosolisation of spray‐dried powders for pulmonary gene therapy

  2005cited by this paper
• Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery.

  2005cited by this paper
• The influence of formulation components on the aerosolisation properties of spray-dried powders.

  2005cited by this paper
• Microencapsulated chitosan nanoparticles for lung protein delivery.

  2005cited by this paper
• The use of absorption enhancers to enhance the dispersibility of spray‐dried powders for pulmonary gene therapy

  2005cited by this paper
• The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins

  2005cited by this paper
• Effect of amino acids on the dispersion of disodium cromoglycate powders.

  2005cited by this paper
• Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.

  2004cited by this paper
• Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.

  2004cited by this paper
• How Much Particle Surface Corrugation Is Sufficient to Improve Aerosol Performance of Powders?

  2004cited by this paper
• Theophylline particle design using chitosan by the spray drying.

  2004cited by this paper
• The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.

  2004cited by this paper
• Aerosolization properties, surface composition and physical state of spray-dried protein powders.

  2004cited by this paper
• The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method

  2003cited by this paper
• The Development of a Modified Dissolution Method Suitable for Investigating Powder Mixtures

  2002cited by this paper
• Preparation of dry powder dispersions for non‐viral gene delivery by freeze‐drying and spray‐drying

  2002cited by this paper
• Use of Solid Corrugated Particles to Enhance Powder Aerosol Performance

  2001cited by this paper
• Spray-dried powders as nasal absorption enhancers of cyanocobalamin.

  2001cited by this paper
• Sustained Release Drug Delivery to the Lungs

  2000cited by this paper
• Solid–liquid equilibrium of α-lactose in ethanol/water

  2000cited by this paper
• Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres.

  1999cited by this paper
• Chitosan and its use as a pharmaceutical excipient.

  1998cited by this paper
• Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications.

  1991cited by this paper
• FACTORS GOVERNING SURFACE MORPHOLOGY OF SPRAY-DRIED AMORPHOUS SUBSTANCES

  1985cited by this paper
• Spray drying handbook

  1979cited by this paper

• Evaluation of the Combination of L‑leucine to Chitosan on Sustained Release of Inhalable Heparin Sodium Microparticles

  2025cites this paper
• Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics.

  2024cites this paper
• Improving the dynamic properties of silk particles by co-spray drying with L-leucine

  2022cites this paper
• Effect of pretreatments and solar tunnel dryer zones on functional properties, proximate composition, and bioactive components of pumpkin (Cucurbita maxima) pulp powder

  2022cites this paper
• Development of a new indole derivative dry powder for inhalation for the treatment of biofilm-associated lung infections.

  2022cites this paper
• Inhaled fixed-dose combination powders for the treatment of respiratory infections

  2021cites this paper
• Machine learning approach for carrier surface design in carrier-based dry powder inhalation

  2021cites this paper
• Surface modification strategies for high-dose dry powder inhalers

  2021cites this paper
• The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges

  2020cites this paper
• PULMONARY DELIVERY OF RESVERATROL-LOADED NANOCOMPOSITE MICROPARTICLES TO TREAT LUNG CANCER

  2020cites this paper
• Prospection of recent chitosan biomedical trends: Evidence from patent analysis (2009-2020).

  2020cites this paper
• Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

  2019cites this paper
• DPI formulations for high dose applications - Challenges and opportunities.

  2018cites this paper
• Future of nanomedicines for treating respiratory diseases

  2018cites this paper
• Antibacterial Loaded Spray Dried Chitosan Polyelectrolyte Complexes as Dry Powder Aerosol for the Treatment of Lung Infections

  2017cites this paper
• Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems

  2016cites this paper
• Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics*

  2016cites this paper
• Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.

  2016cites this paper
• Amorphous powders for inhalation drug delivery.

  2016cites this paper
• Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.

  2016cites this paper
• Formulation Design of Dry Powders for Inhalation.

  2015cites this paper
• Excipient-free, spray-dried powders for pulmonary aztreonam delivery

  2015cites this paper
• Powder, capsule and device: An imperative ménage à trois for respirable dry powders.

  2015cites this paper
• Inhaler Systems: Dry Powder

  2015cites this paper
• Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation

  2015cites this paper
• The influence of amino acids on aztreonam spray-dried powders for inhalation

  2015influential citation
• Engineering hydrophobically modified chitosan for enhancing the dispersion of respirable microparticles of levofloxacin.

  2014cites this paper
• A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection

  2014cites this paper
• MULTI-COMPONENT MICROPARTICULATE/NANOPARTICULATE DRY POWDER INHALATION AEROSOLS FOR TARGETED PULMONARY DELIVERY

  2014cites this paper
• Synthesis and toxicological evaluation of a chitosan-L-leucine conjugate for pulmonary drug delivery applications.

  2014cites this paper
• Research Article Formulation and Evaluation of Combination Dry Powder for Inhalation: Influence of Crystalline Excipient

  2013cites this paper
• Formulation and Evaluation of Combination Dry Powder for Inhalation: Influence of Crystalline Excipient

  2013cites this paper
• The crystal engineering of salbutamol sulphate via simulated pulmonary surfactant monolayers.

  2013cites this paper
• Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity.

  2013cites this paper
• Triggering effect of N-acetylglucosamine on retarded drug release from a lectin-anchored chitosan nanoparticles-in-microparticles system.

  2013cites this paper
• Improvement of Bioavailability and Solubility of Telmisartan by Solid Dispersion Technique using Various Carriers

  2013cites this paper
• In vitro Pseudomonas aeruginosa biofilms: Improved confocal imaging and co-treatment with dispersion agents and antibiotics

  2013cites this paper
• Chitosan and inhalers: a bioadhesive polymer for pulmonary drug delivery

  2013cites this paper
• Development of Engineered Micro-Particles via Spray Drying for Respiratory Drug Delivery

  2013cites this paper
• Spray drying of monodispersed microencapsulates: implications of formulation and process parameters on microstructural properties and controlled release functionality

  2012cites this paper
• Smokeless tobacco use in pediatric population: What is the role of a Dental Surgeon in India?

  2012cites this paper
• Advances in Pulmonary Delivery of Nanoparticles

  2012cites this paper
• The lungs and drug delivery

  2012cites this paper
• Release characteristics of vitamin E incorporated chitosan microspheres and in vitro–in vivo evaluation for topical application

  2011cites this paper
• SUSTAINED RELEASE OF SPRAY-DRIED COMBINATION DRY POWDER INHALER FORMULATION FOR PULMONARY DELIVERY Research Article

  2011cites this paper
• Excipients Utilized for Modifying Pulmonary Drug Release

  2011cites this paper
• Polymers for Pulmonary Drug Delivery

  2011cites this paper
• Development of inhalable dry powder antibiotics and on-bead transcription strategies

  2011cites this paper
• Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery.

  2011cites this paper
• Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.

  2011cites this paper
• Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice.

  2011cites this paper
• Towards crystal engineering via simulated pulmonary surfactant monolayers to optimise inhaled drug delivery.

  2011cites this paper
• Production of pH-responsive microparticles by spray drying: investigation of experimental parameter effects on morphological and release properties.

  2011cites this paper
• Oral Drug Delivery Systems Comprising Altered Geometric Configurations for Controlled Drug Delivery

  2011cites this paper
• A quadruped study on chitosan microspheres containing atorvastatin calcium: preparation, characterization, quantification and in-vivo application.

  2010cites this paper
• The potential of chitosan for pulmonary drug delivery

  2010cites this paper
• Pulmonary Formulations: What Remains to be Done?

  2010cites this paper
• Can low-dose combination products for inhalation be formulated in single crystalline particles?

  2010cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA DISCIPLINA DE TRABALHO DE CONCLUSÃO DE CURSO Desenvolvimento tecnológico de micropartículas de quitosana obtidas por spray- dryer para administração pulmonar de dapsona

  2010cites this paper